MAMarco Arellano

Marco Arellano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marco Arellano has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of colorectal symptoms and anal incontinence in patients with pelvic organ prolapse attended at an outpatient urogynecology service

    by Marco Arellano, Fernanda Santis-Moya, Andrea Maluenda, Alejandro Pattillo, Bernardita Blümel, Dominga Pohlhammer, Silvana Gonzalez, Javier Pizarro-Berdichevsky

    Objective: To analyze data of patients with symptomatic pelvic organ prolapse evaluated with PFDI20 and its subscales to report the prevalence of lower gastrointestinal symptoms and anal incontinence in the population of a public hospital and analyze its impact on quality of life. Methods: Cross-sectional study of patients with symptomatic POP. Patients were evaluated […] Abstract Objective: To analyze data of patients with symptomatic pelvic organ prolapse evaluated with PFDI20 and its subscales to report the prevalence of lower gastrointestinal symptoms and anal incontinence in the population of a public hospital and analyze its impact on quality of life. Methods: Cross-sectional study of patients with symptomatic POP. Patients were evaluated […]


  • Association between pelvic floor disorder symptoms and QoL scores with depressive symptoms among pelvic organ prolapse patients

    by Javier Pizarro‐Berdichevsky, Mario Javier Hitschfeld, Alejandro Pattillo, Bernardita Blumel, Silvana Gonzalez, Marco Arellano, Rodrigo Cuevas, Jacobo Alvo, Ariel Gorodischer, Claudia Flores‐Espinoza, et al.

    Background: There is no consensus on the relationship between depressive symptoms (DS) and pelvic organ prolapse (POP) symptoms and quality of life (QoL). Our hypothesis was that women with DS and POP have worse symptoms and QoL than those without DS and POP.Aim: Our aim was to compare two groups of POP patients, those with depressive symptoms and those without, and evaluate the association of symptoms and QoL.Materials and methods: This planned report is part of a prospective study evaluating the impact of pessary use among symptomatic POP patients. Patients were evaluated by POP quantification (POP‐Q), pelvic ultrasound (US), voiding diaries, stress test, pad test, Pelvic Floor Distress Inventory (PFDI‐20), Prolapse QoL (P‐QoL) and the Goldberg Health Questionnaire (GHQ‐12) (psychological health screening for DS when score ≥5). A sample size of 78 patients was required to demonstrate a 50‐point difference in the global PFDI‐20 score with 80% power and 95% probability.Results: Ninety‐one women with POP were included. GHQ‐12 was positive in 47 (51.6%) patients. No differences were found in POP‐Q, pad and stress test between those with a positive GHQ‐12 and those without. However, GHQ‐12 was associated with higher PFDI‐20 scores and higher scores in seven of nine P‐QoL domains. GHQ‐12 persisted as an independent risk factor for worse P‐QoL scores after multivariable analysis.Conclusion: A ‘positive’ screening for DS was associated with worse PFDI‐20 and P‐QoL scores despite no difference in objective measurements. It may be that depressed patients interpret their symptoms differently.